Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

The U.S. Food and Drug Administration (FDA) announced that Vyaire Medical has recalled the twin tube samples lines from its Vyntus CPX Metabolic Cart due to ongoing safety concerns. This is a Class I recall, which means the FDA believes using these devices “may cause serious injuries or death.”

FDA announces new Class I recall of CPET devices due to choking hazard

If left unchecked, the devices could put patients at risk of serious injuries or death as they undergo cardiopulmonary evaluations. 

Women remain underrepresented in revascularization trials—can cardiology leaders reverse that trend?

“If together we do not just hope for, but demand, adequate representation as a necessary criterion for high-quality studies worthy of adoption into practice, we will have a real shot at achieving true equity in our trials," cardiologists said in a new commentary.

HRS president Jodie Hurwitz, MD, discusses trends in electrophysiology at the 2024 HRS meeting.

Exploring the biggest trends at HRS 2024

Heart Rhythm Society President Jodie Hurwitz, MD, told Cardiovascular Business that pulsed field ablation was one of the hottest topics at Heart Rhythm 2024. It may be early, she said, but the technology is already making an impact. 

WearLinq's eWave six-lead wearable ECG monitor

Wearable ECG specialists acquire new testing facility to reach more patients

San Francisco-based WearLinq says the acquisition will help its six-lead ECG technology reach more heart patients throughout the United States.   

The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA

Biosense Webster Varipulse PFA system performs well with minimal adverse events

"This was the first PFA IDE study to support a substantial number of fluoro-free procedures," said presenter Vivek Reddy, MD.

HeartFlow Plaque Analysis

AI-powered coronary plaque assessments show ‘strong agreement’ with IVUS

HeartFlow's noninvasive Plaque Analysis technology, which uses AI to evaluate CCTA images, delivered assessments that mostly lined up with IVUS results. 

Atraverse Medical Hotwire radiofrequency (RF) guidewire

Medical device startup gains FDA clearance for new RF guidewire, raises $12.5M

Atraverse Medical, a San Diego-based medical device company founded in 2022, designed the guidewire to give physicians as much freedom as possible while treating heart patients. 

AI-based CAD assessments dramatically improve vascular surgery outcomes

PAD patients evaluated with HeartFlow's noninvasive FFRCT Analysis technology prior to surgery experienced much better outcomes, including a 63% lower risk of all-cause mortality after five years. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup